Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer’s disease and apoE TR mouse cortex

Overview of attention for article published in Acta Neuropathologica, October 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 42 Dimensions

Readers on

mendeley: 74 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

METHOD AND COMPOSITION FOR EVALUATING RESPONSE TO NEURODEGENERATIVE DISEASE TREATMENT…

Application WO-2021210897-A1

World Intellectual Property Organisation (WIPO)

METHOD FOR THE DIAGNOSIS AND/OR THE PROGNOSIS OF MYOTONIC DYSTROPHY TYPE 1 (DM1)

Application WO-2015052654-A1

World Intellectual Property Organisation (WIPO)

Methods for the diagnosis and/or the prognosis of Myotonic Dystrophy type 1 (DM1)

Application EP-2860526-A1

European Patent Office